Associations between maternal mid-pregnancy apolipoprotein A-1, apolipoprotein B, apolipoprotein B/apolipoprotein A-1

Qing Liu1, Li Wu2, Lulin Wang1

  • 1Department of Maternal and Child Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China; Key Laboratory of Environment and Health, Ministry of Education & Ministry of Environmental Protection, and State Key Laboratory of Environmental Health (Incubation), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

Insights

Elevated maternal apolipoprotein B (ApoB) and ApoB/ApoA-1 ratio in mid-pregnancy are linked to a higher risk of preterm birth. Monitoring these lipid markers may help identify at-risk pregnancies.

Area of Science:

  • Reproductive Medicine
  • Biochemistry
  • Public Health

Background:

  • Elevated lipid levels in pregnancy are associated with preterm birth risk.
  • Apolipoproteins (Apo) are crucial for lipid metabolism, but their role in pregnancy and preterm birth is understudied.

Purpose of the Study:

  • To investigate the association between maternal serum apolipoprotein A-1 (ApoA-1), apolipoprotein B (ApoB), and the ApoB/ApoA-1 ratio with preterm birth risk.

Main Methods:

  • Data from 5,986 maternal-newborn pairs at Guangdong Women and Children Hospital.
  • Maternal serum ApoB, ApoA-1, and ApoB/ApoA-1 ratio measured in mid-pregnancy (median 18 weeks).
  • Logistic regression models used to calculate odds ratios (OR) and 95% confidence intervals (CI) for preterm birth.

Main Results:

  • Preterm birth occurred in 5.7% of cases.
  • High ApoB (>90th percentile) was associated with increased preterm birth risk (OR: 1.51, 95% CI: 1.06-2.10).
  • High ApoB/ApoA-1 ratio (>90th percentile) also increased preterm birth risk (OR: 1.64, 95% CI: 1.18-2.24).
  • Low ApoB (<10th percentile) showed a protective association (OR: 0.63, 95% CI: 0.38-0.99).
  • Associations were significant in specific subgroups: women with BMI 18.5-24 kg/m² and women aged ≥35 years.

Conclusions:

  • Elevated maternal ApoB and ApoB/ApoA-1 ratio in mid-pregnancy are significant predictors of increased preterm birth risk.
  • Monitoring serum apolipoprotein levels could aid in identifying pregnancies at high risk for preterm birth.
  • Further research may elucidate the precise mechanisms linking these lipid markers to adverse pregnancy outcomes.
Abstract

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
424
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.6K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
107
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
2.8K
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
32